Ayala Pharmaceuticals Inc (ADXS)

[Zoltarak]

What we know:
Amgen is out.
PPS in steady decline.
Book value < cash on hand == value of tech at $0

What we don't know:
Why did Amgen cancel?
Results on trials? (2019)
Management response to Amgen cancellation?


Take-aways:
Near term indicators say cash issue must be resolved and there are very limited options from what "we know"

Management silence - why?


This entire situation is very unsettling and very volatile. Not enough information to make an investment decision, unless you simply want to cut losses and move on.

After management speaks, it should be more clear in terms of options (i.e. other funding, r/s, etc.)